Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Pre-DICTED Program
NCT03503942Completed
- Sponsor
- Singapore General Hospital
- Start
- Dec 2017
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin in prediabetes (2 arms), sponsored by Singapore General Hospital. Primary endpoint: Diabetes incidence at 3 years. Started Dec 2017; status: completed.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT03503942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03503942.